Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

Do you recommend resection for positive anterior or posterior margins in a patient s/p mastectomy if the surgeon says they took all the breast tissue anteriorly to the skin or posteriorly to the fascia?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

It's hard to localize a margin positive area after mastectomy (unlike lumpectomy) and most of the time we dont recommend resection unless the area can be localized with certainty

How do you approach selection of dose and fractionation for definitive treatment of localized skin cancers?

3
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

I presume the question applies to non melanoma skin cancers, i.e. basal cell or squamous. These lesions were frequently treated with RT years ago before the advent of Mohs surgical techniques but are now seldom seen in RT departments. Too bad, because in my experience, relatively short courses of RT...

For patients with laryngeal cancer about to start chemoRT who have a narrow airway on imaging but are asymptomatic without any stridor or shortness of breath, do you take any precautions to prevent airway obstruction secondary to radiation-induced edema?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Iowa

I base my decision on my endoscopy. I feel it's important that radiation oncologists treating head and neck cancer perform their own endoscopy to assess the tumor extent and airway. Imaging (ie CT) can be deceiving depending on cough/clearing throat/holding breath at the time of scan. Converse with ...

Is a completion axillary dissection required for a patient with clinical N+ disease who had a complete clinical response in the axilla to neoadjuvant systemic therapy but is found to ypN+ disease on sentinel node biopsy?

3
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Beth Israel Deaconess Medical Center

Only a few published studies present sufficiently detailed subgroup data to determine rates of axillary failure or total regional nodal failure for patients having sentinel node biopsy (SNB) after neoadjuvant chemotherapy (NACT) after finding either isolated tumor cells (ITC), micrometastases, or ma...

What size cut-off do you suggest for the safe administration of SRS in the setting of brain metastases?

2
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · St. Francis Radiation Oncology

The likelihood of radiation necrosis or acute treatment related imaging change does seem to increase with larger lesion size. I get worried once the target approaches 3 cm in diameter but have treated selected patients beyond that out to 4 cm using 15 - 16 Gy. We have an ongoing trial of dose select...

How do you counsel patients with NF1 diagnosed with breast cancer regarding breast radiation?

6
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · AdventHealth Orlando (previously Florida Hospital)

These patients tend to present with more aggressive breast cancers (higher grade and stage, and higher incidence of contralateral disease). They are also thought to be at increased risk of radiation-induced malignancy (including sarcomatous changes). In addition, screening and surveillance are chall...

Would you offer consolidative radiotherapy for oligometastatic NSCLC?

3
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Michigan Healthcare Professionals, PC

These are extremely challenging cases and the recent negative studies have somewhat dampened my enthusiasm. It has been challenging, in general, to obtain authorization for treatment in these cases and the release of this data will not make it any easier. And as experts note, there are multiple bin...

Would you offer a patient with “good-risk” DCIS and an elevated DCISionRT score APBI or WBI?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Based on the technical suitability, either option is fine.

How do you manage a glioblastoma of the brainstem/upper cervical spinal cord?

3
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Colorado School of Medicine

It used to be that we didn’t get biopsies in this location, and we treated suspected astrocytic tumors in the brainstem/upper spinal cord to 54 Gy in 30 fractions without tissue. The outcome was never good. But now we generally have at least a stereotactic biopsy. The outcome is still not good of co...

Would you transition from denosumab to anabolic agents in patients who are in urgent need for extensive dental work?

6
2 Answers

Mednet Member
Mednet Member
Endocrinology · Boston University School of Medicine

From my experience, this is a catch-22. If you stop the Denosumab you will markedly increase osteoclastic activity throughout the entire skeleton which is why it is recommended that you not stop the medication without some other intervention. I have had several patients with either osteonecrosis of ...